CONGENITAL NEPHROGENIC DIABETES INSIPIDUS IN CHILDREN AND ADOLESCENTS. THE NEW STRATEGY OF THERAPY
https://doi.org/10.24884/1561-6274-2017-3-9-17
Abstract
The article presents modern data on the diagnosis, course, traditional and new treatment strategy of congenital nephrogenic diabetes insipidus (NDI) in children and adolescents.
About the Authors
N. D. Savenkova
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Prof., MD, PhD, DMedSci., Head of department of faculty pediatrics,
194100, St-Petersburg, Litovskaya st., 2
O. A. Semenova
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Assistant professor, MD, PhD, Department of faculty pediatrics,
194100, St-Petersburg, Litovskaya st., 2
A. A. Stepanova
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Assistant professor, MD, PhD, Department of faculty pediatrics,
194100, St-Petersburg, Litovskaya st., 2
References
1. OMIM: An online catalog of human genes and genetic disorders [Electronic resource]. Electronic data. Baltimore: Johns Hopkins Univ., 2015. Mode of access: http://www.moim.org/
2. Knoers N, Levtchenko EN. Nephrogenic diabetes insipidus. In: ED Avner, WE Harmon, P Niaudet, N Yoshikawa. Pediatric nephrology: 6-th edition. Berlin-Heidelberg: Springer-Verlag, Vol. 1, Sections 1-6, 2009; 1005-1018. ISBN 978-3-540-76341-32
3. McIraith CH. Notes on some cases of diabetes insipidus with marked family and hereditary tendencies. Lancet 1892; ii:767-768
4. Williams RH, Henry C. Nephrogenic diabetes insipidus; transmitted by females and appearing during infancy in males. Annals of internal medicine 1947;27(1):84-95
5. Наточин ЮВ. Клиническая физиология почек у детей. В: Папаян АВ, Савенкова НД. Клиническая нефрология детского возраста. Руководство для врачей. С-Пб: «Левша. Санкт-Петербург»; 2008: 19-56 [Natochin JuV. Klinicheskaja fiziologija pochek u detej. V: Papajan AV, Savenkova ND. Klinicheskaja nefrologija detskogo vozrasta. Rukovodstvo dlja vrachej. S-Pb: «Levsha. Sankt-Peterburg»; 2008: 19-56]
6. Bichet DG. Nephrogenic Diabetes Insipidus: Vasopressin Receptor Defect. In: Genetic Diseases of the Kidney. Edited by RP.Lifton, S.Somlo, G. Giebsch, DW.Seldin. ELSEVIER 2009; 341-349
7. Wesche D, Deen P, Knoers N. Сongenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol 2012;27(12):2183-2204. DOI 10.1007/s00467-012-2118-8
8. Sands JM, Layton HE. The physiology of urinary concentration: an update. Semin Nephrol 2009;29(3):178–195. doi: 10.1016/j.semnephrol.2009.03.008
9. Sands JM, Layton HE. The urine concentrating mechanism and urea transporters. In: Alpern RJ, Hebert S.C., editors. The Kidney: Physiology and Pathophysiology. Vol. 1. San Diego: Academic Press; 2008; 1143–1178
10. Deen PMT,Van Os CH, Knoers NVAM. Nephrogenic Diabetes Insipidus: Aquaporin-2 Defect. In:Genetic Diseases of the Kidney. Edited by RP.Lifton, S.Somlo, G. Giebsch, W.Seldin. ELSEVIER 2009; 311-362
11. Bockenhauer D. Diabetes Insipidus. In: Denis F.Geary, Franz Schaefer, editors. The Kidney: Comprehensive Pediatric Nephrology: MOSBY, 2008; 489–498
12. Bichet DG, Bockenhauer D. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best Pract Res Clin Endocrinol Metab 2016; 30 (2):263-276. doi: 10.1016/j.beem.2016.02.010
13. Klein JD, Wang Y, Blount MA et al. Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts. Am J Physiol Renal Physiol 2016;310(10):F1008
14. Klein JD, Fröhlich O, Blount MA et al. Vasopressin increases plasma membrane accumulation of urea transporter UT-A1 in rat inner medullary collecting ducts. J Am Soc Nephrol. 2006;17:2680–2686
15. Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 2015;11(10):576-588. doi: 10.1038/nrneph.2015.89
16. Rascher W, Rosendahl W, Henrichs IA et al. Congenital nephrogenic diabetes insipidus – vasopressin and prostaglandins in respons to treatment with hydrochlorothiazide and indomethacin. Pediatr Nephrol (1987) 1(3): 485-90
17. Jakobsson В, Berg U. Effect of hydrochlorothiazide and indomethacine treatment оn renal function in nephrogenic diabetes insipidus. Acta Paediatr 1994; 83(5): 522-525
18. Knoers N, Monnens LAH. Nephrogenic diabetes insipidus: clinical symptoms, pathogenlsis, genetics and treatment. Pediatr Neprol 1992; 6: 476-482
19. Kilchlechner V, Koller DY, Seidl R, Waldhauser F. Treatment of nephrogenic diabetes insipidus with hydrochlorthiazide and amiloride. Arch Dis Child 1999; 80: 548-552
20. Папаян КА, Савенкова НД. Особенности течения ренального несахарного диабета у детей при лечении гипотиазидом и амилоридом. В: Сборник трудов III нефрологического семинара. Санкт-Петербург (1995): 303-304 [Papayan KA, Savenkova ND Osobennosti techeniya renalnogo nesaharnogo diabeta u detey pri lechenii gipotiazidom i amiloridom. V: Sbornik trudov III nefrologicheskogo seminara. Sankt-Peterburg (1995): 303-304]
21. Семенова ОА, Савенкова НД, Папаян КА. Врожденный нефрогенный несахарный диабет. В: Папаян АВ, Савенкова НД. Клиническая нефрология детского возраста. Руководство для врачей. С-Пб: «Левша. Санкт-Петербург»; 2008: 241-249 [Semenova OA, Savenkova ND, Papajan KA. Vrozhdennyj nefrogennyj nesaharnyj diabet. V: Papajan AV, Savenkova ND. Klinicheskaja nefrologija detskogo vozrasta. Rukovodstvo dlja vrachej. S-Pb: «Levsha. Sankt-Peterburg»; 2008: 241-249]
22. Li JH, Chou CL, Li B et al. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J Clin Invest 2009; 119:3115. doi:10.1038/nrneph.2015.89
23. Sands JM, Klein JD. Physiological insights into novel therapies for nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 2016;311(6):F1149-F1152. doi: 10.1152/ajprenal.00418.2016
24. Assadi F, Sharbaf FG. Sildenafil for the Treatment of Congenital Nephrogenic Diabetes Insipidus. Am J Nephrol 2015;42(1):65-69
25. Cheung PW, Nomura N, Nair AV et al. EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption. J Am Soc Nephrol 2016;27(10);3105-3116. DOI:10.1681/ASN.2015080903
26. Semenova OA, Savenkova ND. Long-term follow-up of patients from 13 families with congenital nephrogenic diabetes insipidus (NDI). Abstracts 42-nd Annual ESPN meeting, September 11-14 2008, Lyon, France. Pediatr Neprol 2008;23(9):1692
Review
For citations:
Savenkova N.D., Semenova O.A., Stepanova A.A. CONGENITAL NEPHROGENIC DIABETES INSIPIDUS IN CHILDREN AND ADOLESCENTS. THE NEW STRATEGY OF THERAPY. Nephrology (Saint-Petersburg). 2017;21(3):9-17. (In Russ.) https://doi.org/10.24884/1561-6274-2017-3-9-17
Views:
8471
Email this article 